These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8212304)

  • 1. Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients.
    Snydman DR
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):25-6. PubMed ID: 8212304
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperimmune immunoglobulin therapy for cytomegalovirus infections in renal transplant patients.
    Brown CB; Nicholls AJ; Edward N; Cuthbertson B; Yap PL; McClelland DB
    Proc Eur Dial Transplant Assoc; 1983; 20():271-9. PubMed ID: 6318221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection in pediatric liver recipients. A virological survey and prophylaxis with CMV immune globulin and early DHPG treatment.
    Dussaix E; Wood C
    Transplantation; 1989 Aug; 48(2):272-4. PubMed ID: 2547257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.
    Snydman DR; Werner BG; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS; Strom TB; Carpenter CB
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1357-60. PubMed ID: 1846464
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of life-threatening infections in renal transplant recipients with high-dose intravenous human IgG.
    Condie RM; Hall BL; Howard RJ; Fryd D; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):66-8. PubMed ID: 222019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cytomegalovirus infection and effects of cytomegalovirus immune globulin prophylaxis after orthotopic liver transplantation.
    Saliba F; Gugenheim J; Samuel D; Bismuth A; Mathieu D; Serres C; Bismuth H
    Transplant Proc; 1987 Oct; 19(5):4081-2. PubMed ID: 2823435
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus immune globulin for the prevention of primary CMV disease in renal transplant patients: analysis of usage under treatment IND status. The Treatment IND Study Group.
    Werner BG; Snydman DR; Freeman R; Rohrer R; Tilney NL; Kirkman RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1441-3. PubMed ID: 8382875
    [No Abstract]   [Full Text] [Related]  

  • 10. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation.
    Basadonna G; Feria A; Perez R; Klein H; Sturges M; Colquhoun S
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):52-3. PubMed ID: 7940976
    [No Abstract]   [Full Text] [Related]  

  • 12. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CMV immune prophylaxis in patients at risk of primary CMV infection following orthotopic liver transplantation.
    Bell R; Sheil AG; McDonald JA; McCaughan GW
    Transplant Proc; 1989 Oct; 21(5):3781-2. PubMed ID: 2554546
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus immune globulin in renal-transplant recipients.
    N Engl J Med; 1988 Apr; 318(16):1065-7. PubMed ID: 2832759
    [No Abstract]   [Full Text] [Related]  

  • 16. CMV hyperimmune globulin prophylaxis after liver transplantation: a prospective randomized controlled study.
    Saliba F; Arulnaden JL; Gugenheim J; Serves C; Samuel D; Bismuth A; Mathieu D; Bismuth H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2260-2. PubMed ID: 2540564
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.
    George MJ; Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):22-4. PubMed ID: 8212303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytomegalovirus infections after kidney transplantation and passive immunization].
    Wienand P; Grundmann R; Runde A; Zippel C
    Immun Infekt; 1985 Sep; 13(5):203-9. PubMed ID: 2998975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.